BioSpace News Archive

Biotech Bay

HumanFirst Opens Up Atlas Platform to Scale Use of Decentralized Clinical Trials

Offering complimentary access to searchable data on thousands of connected sensors to measure digital biomarkers in clinical trials, HumanFirst gives biopharma a new solution to navigate the rapidly evolving landscape of connected health products.

January 18, 2022
·
2 min read
Biotech Beach

BiologyWorks k(now)™ COVID-19 Clinical Trial Matches 99.1% Accuracy to RT-PCR Tests

BiologyWorks k(now)™ Handheld Molecular Testing Device Among the Most Accurate for COVID-19.

January 18, 2022
·
2 min read
Business

Exo Therapeutics Appoints Antonio Gualberto as President of Research & Development and Chief Medical Officer

Exo Therapeutics, Inc. today announced the appointment of Antonio Gualberto, MD, PhD, as President of Research & Development and Chief Medical Officer.

January 18, 2022
·
2 min read
Business

Silence Therapeutics’ Head of Molecular Design Dr. Marie Wikström Lindholm Appointed to Oligonucleotide Therapeutics Society Board of Directors

Silence Therapeutics plc is pleased to announce that Dr. Marie Wikström Lindholm, Senior Vice President, Molecular Design and member of the Silence Executive Leadership Team, has been elected to serve for two years at the Board of Directors.

January 18, 2022
·
3 min read
Business

XyloCor Therapeutics Expands Leadership Team with Accomplished Pharmaceutical Executives to Accelerate Clinical Development Programs and Drive Corporate Growth

XyloCor Therapeutics today announced that it has appointed Elizabeth Tarka, M.D. as Chief Medical Officer and A. Brian Davis as Chief Financial Officer.

January 18, 2022
·
4 min read
Business

OnKure Therapeutics Appoints Nicholas A. Saccomano, Ph.D., to its Board of Directors

OnKure, Inc today announced the appointment of Nicholas A. Saccomano, Ph.D., to its Board of Directors.

January 18, 2022
·
2 min read
Business

CorVista Health Appoints Charles R. Bridges as Chief Scientific Officer

CorVista Health, Inc. announces the appointment of Charles R. Bridges, M.D., Sc.D., as Executive Vice President and Chief Scientific Officer.

January 18, 2022
·
3 min read
Drug Development

Sierra Oncology Updates Topline Data Timing for Pivotal Phase 3 Trial of Momelotinib in Myelofibrosis

Sierra Oncology, Inc. today announced it has shortened the timeline to the topline data readout of the MOMENTUM pivotal Phase 3 trial of momelotinib in patients with myelofibrosis.

January 18, 2022
·
4 min read
Deals

EV Biologics Updates on FINRA

EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its submitted FINRA applications for name change and NFT dividend distribution.

January 18, 2022
·
4 min read
Business

Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to Become Publicly Traded via Business Combination with Social Capital Suvretta Holdings Corp. III

ProKidney LP (“ProKidney”), a leading clinical-stage cellular therapeutics company focused on chronic kidney disease (“CKD”), has entered into a definitive agreement to become a publicly traded company.

January 18, 2022
·
19 min read